TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study.

Nancy U Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.